Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1665
| Despition | CDK5 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 85% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1246 | Bestrophin Blocking Peptide (AC1246) | 250 µg | inquiry |
| ACPP-1468 | Human MEIS3 Protein (AC1468) | 5 µg | inquiry |
| ACPP-1198 | PDE6 Alpha Blocking Peptide (AC1198) | 250 µg | inquiry |
| ACPP-1692 | Human GLUL Protein (AC1692) | 5 µg | inquiry |
| ACPP-1706 | Human HPCAL1 Protein (AC1706) | 2 µg | inquiry |
| ACPP-1591 | Mouse VCAM1 Protein (AC1591) | 2 µg | inquiry |
| ACPP-1245 | CRMP2 Blocking Peptide (AC1245) | 250 µg | inquiry |
| ACPP-1516 | Human Insulin Protein, Yeast (AC1516) | 2 mg | inquiry |
| ACPP-1419 | Human TAC3 Protein (AC1419) | 5 µg | inquiry |
| ACPP-1259 | Usherin Blocking Peptide (AC1259) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.